Clinical Decision Support for Atrial Fibrillation and Flutter

NCT ID: NCT05009225

Last Updated: 2024-03-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

4000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Atrial fibrillation (AF) is a major public health problem: it impairs quality of life and independently heightens the risks of ischemic stroke, heart failure and all-cause mortality. AF is a common reason for presenting to emergency departments (ED) in Kaiser Permanente Northern California (KPNC) and is associated with frequent hospitalization. Additionally, inter-facility hospitalization rates for AF vary across KPNC. Improvements in modifiable components of ED AF care could potentially reduce low-yield hospitalizations and the associated costs, patient inconveniences, and complications that can ensue. Real-time clinical decision support systems (CDSS) can transform entrenched physician practices and improve patient outcomes. The investigators will conduct a stepped-wedge cluster randomized trial of a CDSS intervention across 13 KPNC EDs for the comprehensive management of acute AF with the following three aims: 1) To evaluate the impact of the CDSS intervention on index hospitalization rates; 2) To evaluate the impact of the CDSS intervention on ED AF rate and rhythm control process-of-care metrics; and 3) To evaluate the impact of the CDSS intervention on AF stroke prevention actions for eligible participants at the time of ED discharge. The investigators hypothesize that the CDSS intervention will safely reduce index hospitalization rates, improve rate and rhythm control process-of-care metrics, and increase stroke prevention actions for eligible participants at ED discharge and within 30 days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation and Flutter

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comprehensive ED AF management tool

Managing atrial fibrillation (AF) patients in the emergency department (ED) is complex, often requiring many separate decisions: How to best reduce the heart rate? Should emergency physicians attempt cardioversion? If so, how? Does this patient need stroke prevention? The investigators' CDSS provides emergency physicians with a one-stop, evidence-based resource that addresses all aspects of ED AF management.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥18y) KPNC members presenting to the ED with a primary ED diagnosis of atrial fibrillation/flutter (AF/FL). Subjects who meet criteria will be identified electronically within the CDSS tool in the electronic health record.

Exclusion Criteria

* Children (\<18y).
* Non-members of KPNC.
* Patients who were prisoners, pregnant, receiving hospice or palliative care, or who left against medical advice at the index encounter for AF/FL.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaiser Permanente Antioch Emergency Department

Antioch, California, United States

Site Status

Kaiser Permanente Fremont Emergency Department

Fremont, California, United States

Site Status

Kaiser Permanente Manteca Medical Center

Manteca, California, United States

Site Status

Kaiser Permanente Modesto Medical Center

Modesto, California, United States

Site Status

Kaiser Permanente Oakland Emergency Department

Oakland, California, United States

Site Status

Kaiser Permanente Richmond Emergency Department

Richmond, California, United States

Site Status

Kaiser Permanente Roseville Emergency Department

Roseville, California, United States

Site Status

Kaiser Permanente South Sacramento Emergency Department

Sacramento, California, United States

Site Status

Kaiser Permanente Sacramento Emergency Department

Sacramento, California, United States

Site Status

Kaiser Permanente San Francisco Emergency Department

San Francisco, California, United States

Site Status

Kaiser Permanente San Jose Emergency Department

San Jose, California, United States

Site Status

Kaiser Permanente San Leandro Emergency Department

San Leandro, California, United States

Site Status

Kaiser Permanente San Rafael Emergency Department

San Rafael, California, United States

Site Status

Kaiser Permanente Santa Clara Emergency Department

Santa Clara, California, United States

Site Status

Kaiser Permanente South San Francisco Emergency Department

South San Francisco, California, United States

Site Status

Kaiser Permanente Walnut Creek Medical Center

Walnut Creek, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Vinson DR, Warton EM, Durant EJ, Mark DG, Ballard DW, Hofmann ER, Sax DR, Kene MV, Lin JS, Poth LS, Ghiya MS, Ganapathy A, Whiteley PM, Bouvet SC, Rauchwerger AS, Zhang JY, Shan J, DiLena DD, Kea B, Pai AP, Loyles JB, Solomon MD, Go AS, Reed ME. Decision Support Intervention and Anticoagulation for Emergency Department Atrial Fibrillation: The O'CAFE Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 Nov 4;7(11):e2443097. doi: 10.1001/jamanetworkopen.2024.43097.

Reference Type DERIVED
PMID: 39504024 (View on PubMed)

Vinson DR, Rauchwerger AS, Karadi CA, Shan J, Warton EM, Zhang JY, Ballard DW, Mark DG, Hofmann ER, Cotton DM, Durant EJ, Lin JS, Sax DR, Poth LS, Gamboa SH, Ghiya MS, Kene MV, Ganapathy A, Whiteley PM, Bouvet SC, Babakhanian L, Kwok EW, Solomon MD, Go AS, Reed ME; Kaiser Permanente CREST Network. Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAFE trial). Trials. 2023 Mar 31;24(1):246. doi: 10.1186/s13063-023-07230-2.

Reference Type DERIVED
PMID: 37004068 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1279670

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.